ARVN

Conviction 24HealthcareScan · Thu, Sep 24, 2026

Hammer

Arvinas, Inc. (ARVN) closed at $7.80 (-0.38%) on Sep 24, 2026. Its latest daily candle is a hammer. Price is below its 50-day and below its 200-day moving average. RSI(14) 33, RS Rating 71, -43.6% from its 52-week high, -32.0% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

ARVN$7.80-0.38%

ResistanceSupportVol 14Insider sell

Vol MA14 1.04M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

ARVINAS, INC.PHARMACEUTICAL PREPARATIONSwww.arvinas.com ↗

Price7.80

Change-0.38%

Gap-1.53%

Rel volume2.42×

Avg volume894.9K

Avg $ vol7.62M

SMA 208.70

SMA 508.69

SMA 20010.30

Price vs 50-10.19%

Price vs 200-24.25%

MA stackbearish

50/200 cross—

Supertrenddown · 8.71

RSI (14)33

MACD hist-0.11

MACD cross—

Stoch %K / %D20 / 16

ADX (14)18

+DI / −DI16 / 34

RSI divergence—

MACD divergence—

ATR %4.72%

ADR %3.94%

52w high13.83

52w low6.98

From 52w high-43.60%

Above 52w low+11.75%

New 52w highNo

SqueezeOff

Bollinger width24.36%

%B0.07

Donchian pos18.00%

Donchian high9.69

Donchian low7.39

AVWAP (52w high)9.29

vs AVWAP high-16.04%

AVWAP (52w low)8.42

vs AVWAP low-7.40%

OBV trendDown

Chaikin MF (20)0.04

Today vs 20d2.42×

Avg vol (14d)1.04M

Avg vol (20d)894.9K

Avg $ vol (20d)7.62M

Market cap510.01M

RS Rating71 / 99

RS 3m (vs SPY)-7.36%

RS 6m (vs SPY)-45.39%

RS line new highNo

Trend template0/8

Technical rank13.6

1 week-6.14%

1 month-18.75%

3 months-2.86%

6 months-28.57%

1 year+3.59%

YTD-32.00%

P/E-6.31

P/B0.91

P/S10.92

P/FCF-1.85

EPS-1.14

Div yield—

ROE-14.37%

ROA-11.97%

Debt/Eq0.00

Current7.91

EV/EBITDA-3.60

Gross margin—

Net margin-173.02%

Rev growth114.22%

EPS growth59.38%

Price target14.96

Target upside91.79%

Analyst ratingHold

Institutional93.37%

Ent. value416.21M

Revenue249.7M

Net income169.4M

Gross profit—

Free cash flow-275.7M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out64.52M

Employees246

ListedThu, Sep 27, 2018

Free float51.98M

Float %80.6%

Short interest4.71M

Days to cover8.0d

Short volume62.5%

Squeeze score73 / 100

Next earnings—

EPS forecast—

Last EPS vs est$2.58 vs −$0.24

Last surprise+1175.0% beat

Setup gradeD

Conviction24 / 100

Pattern quality—

Tech rank13.6 / 100

Group rank59 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmHammer

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Setting up
Jul 30
1 scan
→
Breaking out now
Aug 4
1 scan
→
Setting up
Sep 4
1 scan

Congress activity

Disclosed STOCK Act trades in ARVN

All disclosures →

No recent disclosed trades by Congress in ARVN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ARVN

Insider	Side	Shares	Value	Traded	Filed
Bain Linda Director · Stock Option (right to buy) · 2026-06-24	Grant	22.71K	—	2026-06-24	2026-06-26
Norwalk Leslie V Director · Common Stock · 2026-06-24	Grant	15.53K	—	2026-06-24	2026-06-26
Bain Linda Director · Common Stock · 2026-06-24	Grant	15.53K	—	2026-06-24	2026-06-26
Cunningham Everett Director · Common Stock · 2026-06-24	Grant	15.53K	—	2026-06-24	2026-06-26
Cunningham Everett Director · Stock Option (right to buy) · 2026-06-24	Grant	22.71K	—	2026-06-24	2026-06-26
Kennedy Edward Moore Jr. Director · Common Stock · 2026-06-24	Grant	15.53K	—	2026-06-24	2026-06-26
Kennedy Edward Moore Jr. Director · Stock Option (right to buy) · 2026-06-24	Grant	22.71K	—	2026-06-24	2026-06-26
Morrison Briggs Director · Common Stock · 2026-06-24	Grant	15.53K	—	2026-06-24	2026-06-26
Morrison Briggs Director · Stock Option (right to buy) · 2026-06-24	Grant	22.71K	—	2026-06-24	2026-06-26
Norwalk Leslie V Director · Stock Option (right to buy) · 2026-06-24	Grant	22.71K	—	2026-06-24	2026-06-26

SEC filings

EDGAR filings in ARVN · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.